This review concluded that there was inadequate evidence to evaluate use of urine myoglobin as a predictor of acute renal failure in patients with suspected rhabdomyolysis. There were limitations in the review and included studies, but the overall conclusion reflected the evidence presented.
Study selection
Studies that used uMb to indicate acute renal failure in at least three patients with suspected rhabdomyolysis were eligible for inclusion. Studies with myoglobinuria as an entry requirement were excluded. Most studies that assessed test performance used random urine collections and used either colorimetric dipstick or immunometric methods for establishing uMb. Where reported, in studies that reported test accuracy cut offs for a positive immunometric test ranged from 2μg/L to more than 20,000 μg/L. Where reported, cause of rhabdomyolysis was trauma, tetanus, birth asphyxia or mixed causes. Prevalence of acute renal failure ranged from 6.3% to 26.5%.
Two reviewers selected studies. Disagreements were resolved by discussion.
Assessment of study quality
Study quality was evaluated using the 14-criteria QUADAS tool.
The authors did not state how many reviewers performed the quality assessment.
Data extraction
Data needed to construct 2x2 tables of test performance were extracted from studies with at least 20 patients and sensitivity and specificity and 95% confidence intervals (CI) were calculated. Positive likelihood ratios (LR+) and positive predictive values (PPV) were reported.
The authors did not state how many reviewers extracted data.
Methods of synthesis
Studies were combined in a narrative synthesis. Differences between studies were discussed in the text. Study details were tabulated.
